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Abstract
There is a growing discrepancy between the supply 
and demand of livers for transplantation resulting in 
high mortality rates on the waiting list. One of the 
options to decrease the mortality on the waiting list is 
to optimize organs with inferior quality that otherwise 
would be discarded. Livers from donation after cardiac 
death (DCD) donors are frequently discarded because 
they are exposed to additional warm ischemia time, 
and this might lead to primary-non-function, delayed 
graft function, or severe biliary complications. In order 
to maximize the usage of DCD livers several new 
preservation approaches have been proposed. Here, we 
will review 3 innovative organ preservation methods: (1) 
different ex vivo  perfusion techniques; (2) persufflation 
with oxygen; and (3) addition of thrombolytic therapy. 
Improvement of the quality of DCD liver grafts could 
increase the pool of liver graft’s for transplantation, 
improve the outcomes, and decrease the mortality on 
the waiting list. 
Key words: Biliarycomplications; Donation after cardiac 
death; Organ preservation methods
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: As the demand for more organs increases, the 
transplant community searches for new approaches 
to expand the pool of organs. Recently developed 
methods to improve the condition of donation after 
cardiac death (DCD) livers look promising. During the 
past decade, ex vivo  machine perfusion method has 
demonstrated positive results and it is considered as 
a new potential preservation method for DCD organs. 
This paper provides an overview of the attempts to 
ameliorate the quality of DCD liver grafts and transplant 
outcomes by improving preservation techniques.
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INTRODUCTION
Liver transplant is considered as the only available 
treatment for patients with end stage liver disease. Liver 
transplantation has been performed with success since 
1963 and the outcomes continue to improve achieving 
1-year graft survival superior to 90%[1,2]. At the same 
time the demand for liver transplant has increased 
and many patients die on the waiting list. The organ 
shortage has led to an increase in the use of grafts with 
inferior quality such as from donation after cardiac death 
(DCD) donors, also called non-heart-beating donors. 
DCD livers undergo additional warm ischemia time 
(WIT) which is associated with inferior liver function and 
poor outcome after transplant. Therefore, searching for 
potential approaches to ameliorate the quality of organs 
from DCD donors and minimizing injury is of special 
importance for the transplantation field. 
In this paper we discuss about the attempts to 
ameliorate the quality of DCD liver grafts by improving 
preservation techniques.
CHARACTERISTICS OF DCD DONORS
DCD donors are characterized by the termination of 
ventilation and blood circulation before cold flushing 
of organs[3]. The idea to use DCD liver grafts was rein-
troduced in the 1990s after achieving success in kidney 
transplantation[3]. The use of grafts from DCD donors 
in the United States has exponentially increased from 
0.95% in 2000 to 5% in 2010 (1 UNOS).
In general DCD donors are divided into uncontrolled 
and controlled donation groups. In the uncontrolled 
group, the organ suffers from prolonged WIT, as the 
potential donor is dead on arrival or has been under-
going unsuccessful resuscitation. In this group, the 
organ suffers from long WIT which is a detrimental 
factor in organ quality. In the controlled group, cardiac 
arrest is planned and it happens following withdrawal of 
ventilator in the operating room or intensive unit care[3,4]. 
It is generally accepted that DCD grafts have less energy 
stores and undergo more damage during the storage 
time[5].
Biliary complications are much more common in 
patients that received grafts from DCD donors (20%-40%
compared to 5% in grafts from brain-dead donors)[6]. 
Post transplant biliary complications could lead to a 
number of serious complications such as graft loss, high 
morbidity which requires re-transplant or could result 
in patient’s death[7]. The most critical type of biliary 
complications are the so-called ischemic-type biliary 
lesions (ITBL), also called ischemic cholangiopathy, with 
an incidence varying between 5% and 15%[8,9]. The risk 
of ischemic cholangiopathy with grafts from DCD donors 
is 10 times higher than for brain dead donors because 
of severe warm ischemia suffered by these grafts[6]. The 
reason why they develop more biliary complications is 
that bile ducts (cholangiocytes) are more sensitive to 
ischemia-reperfusion injury than hepatocytes[10]. Many 
of DCD liver grafts are not used because longer warm 
or cold ischemia times have been associated with poor 
outcomes[6,11,12]. Most of the transplant centers accept 
livers from DCD donors that have a maximum WIT, the 
period between extubation and cold flushing, of less 
than 30 min and short cold ischemia time (in general 
less than 6 h)[11].
OXYGENATED COLD STORAGE 
(PERSUFFLATION)
Simple cold storage (SCS) is the currently widely used 
organ preservation method in the clinical setting because 
of the low cost and simplicity. The idea of CS is to 
decrease the metabolism level to provide protection from 
ischemia. However, even at 4 ℃ there is approximately 
5% active metabolism in the organ which eventually 
leads to ATP depletion and accumulation of waste 
product[13,14]. In order to improve organ preservation 
method, persufflation (PSF) had been introduced as 
an alternative method with the capacity of delivering 
oxygen during cold preservation. PSF has been used 
in rat livers for the first time between 1980 and 1990 
by the Fischer group. They first established the model 
on rodent liver and continued with large animals (pig) 
and were able to demonstrate the benefits of PSF by 
improving the quality of liver grafts[15]. They also showed 
the feasibility of this method by publishing the outcome 
of five patients transplanted with persufflated livers[16]. 
The livers underwent WIT between 20-60 min and 
they were rejected by all the other transplant centers 
for transplant. They were flushed with University of 
Wisconsin (UW) or histidin-tryptophan-ketoglutarate and 
after arriving to the transplant center were subjected 
to retrograde PSF (R-PSF) at 18 mmHg for 70-200 min 
before the implantation. The results were promising and 
during the two years follow-up period, all the recipients 
showed good graft function. Later, in a study done by 
Minor et al[17], it was shown that PSF of Wistar rat liver 
grafts with 18 mmHg of oxygen for 48 h at 4 ℃ could 
lower the activity of Kupfer cells compared to simple 
SCS.
Following these preliminary results, the studies 
were extended to study the effect of PSF in DCD livers. 
Minor et al[18] introduced venous systemic oxygen PSF 
in DCD rat livers following 30 min of WIT. In a following 
study, the same group transplanted livers after 24 
h PSF preservation, which showed that it improved 
mitochondrial function, and normalized ATP level[19].
Following the increasing concern on potential reactive 
oxygen species (ROS) production during PSF, Minor 
et al[20] preserved DCD rat livers for 24 h with R-PSF 
and compared with the result of the livers that were 
preserved in UW solution. The ATP level, bile production 
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and perfusion flow was improved in R-PSF livers. The 
outcome of this study demonstrated the beneficial 
role of R-PSF in eliminating ROS and lipid peroxidation 
production. In another study by Minor et al[21] it was 
also demonstrated that treatment with anti-oxidants 
such as superoxide dismutase or allopurinol during 
normothermic R-PSF could eliminate lipid peroxidation 
and restore the energy level in liver grafts after 60 
min of WIT and 60 min of SCS in Euro-Collins solution. 
They also reported that PSF alone could induce some 
oxidative damage[21]. Recently in a study done by Lüer 
et al[22], it is shown that pulsatile PSF of DCD rat livers 
is beneficial in early graft recovery after reperfusion. In 
this study livers that were procured from male Wistar 
rats were subjected to 30 min WIT and then 18 h of 
cold ischemia. Later the grafts (n = 5 each group) 
were preserved with either nonpulsatile or pulsatile 
gaseous oxygen PSF. Pulsatile PSF demonstrated better 
parenchymal preservation, higher nitric oxide levels in 
perfusate, and decreased portal vein resistance[22].
In the next step, PSF was tested on pig livers, and 
subsequently to human DCD livers. In 2001 Saad et 
al[23] showed that R-PSF with antioxidant treatment in 
a transplant model is a promising method in improving 
the quality of the porcine DCD livers. DCD livers under-
went 60 min WIT followed by 4 h SCS in UW solution 
or R-PSF with antioxidant treatment. In R-PSF group 
all animals survived, while animals in SCS group died 
3 h after transplantation[23]. After successful animal 
experiments, the first clinical study was started in 2004 
in Germany using R-PSF in 5 DCD livers. Liver grafts 
underwent R-PSF at 18 mmHg at least one hour before 
transplantation. Evaluation of the histological biopsies 
taken before and after R-PSF showed that ATP level 
was enhanced by 2-5 times after R-PSF treatment, 
and all the patients survived during the two years of 
observation period with good graft function panel[16].  
HYPOTHERMIC MACHINE PERFUSION
Hypothermic machine perfusion (HMP) is considered 
as one of the alternative preservation methods to SCS 
which have recently been increased in use for DCD grafts 
preservation. HMP is a continuous or pulsatile circulation 
of the cold preservation solution in an organ at 4 ℃-8 ℃, 
and it has already been shown that HMP can resuscitate 
DCD liver graft’s in different rat models[24-26]. Schlegel 
et al[27] demonstrated that hypothermic oxygenated 
perfusion (HOPE) in a rat model could impact down 
regulation of the immune system after transplantation, 
in addition to protecting against ischemia injury. In this 
study, using an acute rejection model, livers from the 
Lewis Rats were used to be transplanted into the Brown 
Norway Rats. Rat livers underwent one hour HOPE 
before implantation with or without low dose (0.03 
mg/kg) tacrolimus treatment in the recipients during the 
four weeks of observation. The combination of tacrolimus 
with HOPE resulted in 100% survival in the recipients 
without any sign of rejection. As it was mentioned prior, 
one of the important issues in using DCD liver is to 
overcome biliary complications, in particular ischemic 
cholangiopathy related to strictures. In 2013, in a study 
done by Schlegel et al[25], it was demonstrated that 
HOPE is a sufficient method to protect DCD livers from 
biliary complications. The rat livers underwent to 30 min 
warm ischemia and it was followed by 4 h SCS. In the 
HOPE group, livers underwent one hour HOPE prior to 
implantation. Subsequently, livers were implanted and 
the recipients were observed for four weeks. Kupffer cell 
and endothelial cell activation was reduced. Moreover, 
cholestasis parameters were also improved in the 
HOPE group. In another study, Op den Dries et al[28] in 
a DCD pig model indicated the efficacy of oxygenated 
hypothermic machine perfusion in decreasing and 
limiting arteriolonecrosis injury of the peribiliary vascular 
plexus of the bile ducts. After 30 min of warm ischemia, 
the livers were preserved by SCS or oxygenated hypo-
thermic machine perfusion using dual perfusion machine 
for 4 h. Next step was liver reperfusion for two hours 
at 37 ℃ with oxygenated autologous blood to simulate 
transplantation. Studying the bile duct histology dis-
closed reduced arteriolonecrosis of the peribiliary 
vascular plexus in the livers that were subjected to HMP 
perfusion vs SCS.
The feasibility of HMP study on human livers of 
brain dead donors was performed by Guarrera et al[29] 
at Columbia University. They used dual perfusion to 
perfuse 20 livers and successfully transplant them. 
They reported reduced early graft dysfunction, peak 
transaminases and improved renal function[29]. The 
first use of HMP for DCD livers was reported in 2014 
by Dutkowski et al[30]. Eight DCD livers with median of 
38 min WIT were included. Liver grafts underwent 1-2 
h HOPE with perfusion pressure at 10 ℃, 3 mmHg. 
After transplantation the grafts revealed good hepatic 
function and no evidence of ITBL. Using HMP in other 
organs such as kidney is more common. There have 
been several clinical trials done on kidney HMP and it 
has become routine to use this method to preserve 
the human kidney in some part of Europe and some 
states in United States. Cold static storage is still the 
most common method of preservation in liver since 
cannulation and perfusion is more complicated in liver, 
and currently there is no Food and Drug Administration 
approved liver perfusion machine for clinical use.
SUBNORMOTHERMIC MACHINE 
PERFUSION
Another new potential method to replace SCS is 
subnormothermic (SNP) machine perfusion. Olschewski 
et al[31] presented that SNP perfusion is more beneficial 
in DCD rat liver which were subjected to one hour 
warm ischemia and reperfused at body temperature. 
Berendsen et al[32] established a rat liver transplant 
model. In this study the livers underwent 3 h of SNP 
perfusion at 21 ℃ with Williams Medium E solution 
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before implantation. The liver graft was retrieved from 
a 57-year-old donor. Circulatory arrest occur 150 min 
after stopping of life-supporting treatment and the graft 
underwent 5 h cold storage. Later the graft was perfused 
at 37 ℃ for 132 min with a plasma free solution. During 
the first 74 min of perfusion, the lactate was decreased 
from 7.2 to 0.3 mmol/L. after implantation the liver 
biochemistry was normal and during 6 mo posttransplant 
observation, there was no evidence of cholangiopathy[37].
GRADUAL REWARMING MACHINE 
PERFUSION
Minor et al[38] for the first time introduced the concept 
of thermally controlled oxygenated rewarming (COR) 
of the liver grafts prior to reperfusion. In this study, 
Porcine livers were subjected to 18 h SCS and then 
were perfused 90 min by COR perfusion, HMP and 
SNP. In the COR group, during the first part of the 
perfusion temperature was stabilized at 8 ℃ and then 
was gradually enhanced to 12 ℃, 16 ℃, and 20 ℃ after 
30 min, 45 min and 60 min, respectively. The perfusion 
pressure was kept at 4 mmHg in the portal side and at 
25 mmHg at the hepatic artery side. In order to mimic 
the anastomosis time, the liver grafts were not perfused 
and were kept for 30 min in room temperature and 
then were reperfused with autologous blood for 4 h. 
The liver in the COR group demonstrated increased 
ATP, decreased lipid peroxidation, enzyme leakage and 
improved bile production. Minor et al[39] suggested that 
starting reoxygenation in a low temperature could reduce 
oxidative stress injury during reperfusion, and improve 
mitochondrial function[40]. Following the previous study 
Westerkamp et al[41] investigated COR in a rat DCD 
model. In this study, the rat DCD livers were subjected 
to SCS at 4 ℃ for 6 h and then subjected to COR, HMP 
or SNP. After 45 min mimic anastomosis time, they 
were reperfused 2 h with red blood cells and Williams 
Medium E solution. In the control group, livers were 
immediately reperfused at 37 ℃. Reduced transaminase 
enzymes level and lipid peroxidation level, superior 
mitochondrial function, higher bile production, improved 
bile quality and better preserved bile duct epithelium 
was observed in the COR group. The COR represented 
superior liver function compare to the SCS groups but 
comparable to the HMP and the SNP group.
ABDOMINAL REGIONAL PERFUSION
The main concept of abdominal regional perfusion 
is to limit deleterious effect of warm ischemia in 
DCD organs by the abdominal organ perfusion with 
continuous flow. Abdominal regional perfusion is being 
done via cannulation of femoral artery and vein using 
cardio pulmonary bypass machine or extracorporeal 
membrane oxygenation machine. For the first time 
regional perfusion was performed by a Spanish surgeon 
at 1989[42]. The perfusion is being used in two categories 
after one hour of WIT[32]. The survival rate was 83.3% 
in a one month observation period. In another study 
perforemd by the same group, they perfused 7 human 
discarded DCD livers at 21 ℃ for 3 h with oxygenated 
Williams Medium E[33]. This study found that oxygen 
uptake and ATP content was improved with an increase 
in bile production, and better bile quality. They suggested 
that SNP perfusion is effective in improving DCD livers 
quality and hepatobiliary cellular parameters. 
NORMOTHERMIC MACHINE PERFUSION
Normothermic machine perfusion (NMP) is one of the 
innovative organ preservation techniques. NMP consists 
of a pulsatile flow of oxygenated perfusion solution in 
the organ which supports cellular metabolism at body 
temperature, restores the energy content of the organ 
and washes out waste products prior to the reperfusion 
in the recipient body. Another advantage of this method 
is to provide the opportunity of assessing the organ 
viability prior to implantation. In 2001, Friend et al[34] 
published a paper in which they described maintaining 
viability of DCD livers for a minimum of 24 h by apply-
ing NMP. After 60 min of WIT the liver grafts were 
stored for 24 h in UW solution or were immediately 
subjected to NMP. To mimic the anastomosis time, 
the livers were not perfused for 45 min after flushing 
with cold preservation solution. After 45 min, livers 
were reperfused for another 24 h. The continuous bile 
production, lower resistance in portal flow, reduced 
alanine transaminase level in the NMP group suggested 
that the quality of preservation can be enhanced by 
NMP perfusion.
op den Dries et al[35] was the first group to report 
the feasibility of this method in human DCD livers. 
They perfused 4 DCD discarded livers for 6 h using a 
dual perfusion system. The perfusion fluid consisted of 
packed blood cells with fresh frozen plasma to provide 
a sufficient support for high metabolism activity at 37 ℃. 
Reduced lactate level to the normal value, bile production, 
and well preserved hepatocytes and biliary sinusoids 
suggested that NMP is beneficial in improving the quality 
of DCD livers. One year later the same group published 
a study on criteria of assessing the graft viability during 
ex vivo NMP perfusion[36]. They investigated whether 
bile production and the quality of the produced bile 
during NMP would be a reliable biomarker for viability 
assessment. Twelve discarded DCD livers with median 
cold storage of 6.5 h were included and subjected to 6 h 
NMP at 37 ℃ with plasma and red blood cells. Liver grafts 
were divided into two groups; high bile production (more 
than 30 g in 6 h, and low bile production (less than 20 
g). Higher bilirubin and bicarbonate concentration in 
the bile samples and lower hepatic necrosis in the high 
bile production group suggested that bile production 
might be a potential biomarker to assess the organ 
viability during warm perfusion. In a recent case report, 
Watson et al[37] from Addenbrooke’s Hospital revealed 
the effect of Normothermic perfusion on a DCD liver graft 
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as hypothermic or normothermic perfusion[43]. One 
group from West forest University describes perfusing of 
six DCD livers with hypothermic regional perfusion which 
was performed at 22 ℃. In this study they showed good 
initial graft survival[44]. The hospital clinic in Barcelona 
started using normothermic regional perfusion protocol 
on human category 2 DCD donors. The recipients were 
subjected to a median 45 mo follow-up. One year graft 
survival was 73% while patient survival rate was 81%. 
In another study a group from La coruna in Spain 
included category 2 DCD liver donors, they subjected 
7 donors to hypothermic regional perfusion and 10 
donors to normothermic regional perfusion. The results 
demonstrated high biliary complication in the recipients 
(25%) with low rate of five years graft survival[45]. 
THROMBOLYTIC THERAPIES (TISSUE 
PLASMINOGEN ACTIVATOR)
Hashimoto et al[46] suggested that the higher incidence 
in biliary complications of DCD livers may be related 
to microthrombi in the peri-biliary plexus. In this 
study they included 22 patients and assessed the 
effect of tissue plasminogen activator (TPA) injected 
into the hepatic artery of donor’s during back table. 
Fourteen recipients out of 22 developed excessive post 
reperfusion bleeding and 2 patients developed ITBS. 
The TPA level was investigated in all the patients to find 
out if there was a correlation between the TPA level and 
excessive bleeding. They found that TPA level in the 
patients with bleeding was comparable with those who 
did not develop bleeding. The patients with excessive 
bleeding had history of higher previous laparotomy 
done in the past and higher body mass index, which 
might be associated with incidence of massive bleeding. 
In another study Seal et al[47] recently showed that 
TPA treatment in DCD liver grafts decreases ITBSs 
occurrence and improves one- and three-year graft 
survival after transplant. TPA injection was delivered into 
the hepatic artery during liver transplant in 85 patients 
and compared to 33 patients who did not undergo TPA 
treatment. They reported lower occurrence rate of ITBL 
(16.5% vs 33.3%) and lower intrahepatic constriction 
in the group that received TPA treatment (3.5% vs 
21.2%).
THE DISADVANTAGES OF DIFFERENT 
PRESERVATION METHODS
The disadvantages of each method are listed in the 
Table 1. 
CONCLUSION
Because of exponential increase in the demand of liver 
grafts and high mortality on the waitlist, the interest 
of expanding the suitable organs for transplant has 
been increased. The optimized use of DCD liver grafts, 
different ex-vivo preservation interventions have 
been proposed achieving high rates of success. There 
is enough evidence that these new techniques have 
potential to improve graft function. Now, it is time for 
randomized controlled trials and a cost-effective analysis 
to determine if these techniques will become standard 
clinical practice. 
ACKNOWLEDGMENTS
The authors would like to thank Stefanie Parker for 
proof-reading and editing.
REFERENCES
1 Starzl TE, Fung JJ. Themes of liver transplantation. Hepatology 
2010; 51: 1869­1884 [PMID: 20235333 DOI: 10.1002/hep.23595]
2 Starzl TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli BJ, 
Malatack JJ, Schade RR, Shaw BW, Hakala TR, Rosenthal JT, 
Porter KA. Evolution of liver transplantation. Hepatology 1982; 2: 
614­636 [PMID: 6749635 DOI: 10.1002/hep.1840020516]
3 Detry O, Le Dinh H, Noterdaeme T, De Roover A, Honoré P, 
Squifflet JP, Meurisse M. Categories of donation after cardio­
circulatory death. Transplant Proc 2012; 44: 1189­1195 [PMID: 
22663982 DOI: 10.1016/j.transproceed.2012.05.001]
4 Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, 
Cooper JT, Shames BD, Becker YT, Odorico JS, Knechtle SJ, 
Sollinger HW, Kalayoglu M, D’Alessandro AM. Donation after 
cardiac death: the University of Wisconsin experience with liver 
transplantation. Ann Surg 2005; 242: 724­731 [PMID: 16244547 
DOI: 10.1097/01.sla.0000186178.07110.92]
5 Berendsen TA, Izamis ML, Xu H, Liu Q, Hertl M, Berthiaume 
F, Yarmush ML, Uygun K. Hepatocyte viability and adenosine 
triphosphate content decrease linearly over time during con­
ventional cold storage of rat liver grafts. Transplant Proc 2011; 43: 
1484­1488 [PMID: 21693222 DOI: 10.1016/j.transproceed.2010.1
2.066]
Table 1  Disadvantages of the different methods
Preservation methods Disadvantages
Persufflation Not able to assess the viability of the grafts
Hypothermic perfusion High cost, not able to assess the viability of the graft
Subnormothermic perfusion High cost, clinical challenging, not able to assess the viability of the graft
Normothermic perfusion High cost, clinical challenging, the blood supply, the risk of losing the graft in the case of emboli in the system
Gradual rewarming High cost, clinical challenging, need an accurate machine to be able to change the temperature and pressure
Abdominal regional perfusion Ethical challenging
Thrombolytic therapies Risk of severe bleeding
Mahboub P et al . Approaches to improve DCD liver grafts
319 June 24, 2016|Volume 6|Issue 2|WJT|www.wjgnet.com
6 Jay CL, Lyuksemburg V, Ladner DP, Wang E, Caicedo JC, Holl 
JL, Abecassis MM, Skaro AI. Ischemic cholangiopathy after 
controlled donation after cardiac death liver transplantation: a 
meta­analysis. Ann Surg 2011; 253: 259­264 [PMID: 21245668 
DOI: 10.1097/SLA.0b013e318204e658]
7 Akamatsu N, Sugawara Y, Hashimoto D. Biliary reconstruction, 
its complications and management of biliary complications after 
adult liver transplantation: a systematic review of the incidence, 
risk factors and outcome. Transpl Int 2011; 24: 379­392 [PMID: 
21143651 DOI: 10.1111/j.1432­2277.2010.01202.x]
8 Cameron AM, Busuttil RW. Ischemic cholangiopathy after liver 
transplantation. Hepatobiliary Pancreat Dis Int 2005; 4: 495­501 
[PMID: 16286251]
9 Verdonk RC, Buis CI, Porte RJ, Haagsma EB. Biliary com­
plications after liver transplantation: a review. Scand J Gastro­
enterol Suppl 2006; (243): 89­101 [PMID: 16782628 DOI: 10.1002/
lt.21165]
10 Noack K, Bronk SF, Kato A, Gores GJ. The greater vulnerability of 
bile duct cells to reoxygenation injury than to anoxia. Implications 
for the pathogenesis of biliary strictures after liver transplantation. 
Transplantation 1993; 56: 495­500 [PMID: 8212138 DOI: 10.1097/
00007890­199309000­00001]
11 Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D’
Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto 
DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB. ASTS 
recommended practice guidelines for controlled donation after 
cardiac death organ procurement and transplantation. Am J 
Transplant 2009; 9: 2004­2011 [PMID: 19624569 DOI: 10.1111/j.
1600­6143.2009.02739.x]
12 Skaro AI, Jay CL, Baker TB, Wang E, Pasricha S, Lyuksemburg 
V, Martin JA, Feinglass JM, Preczewski LB, Abecassis MM. The 
impact of ischemic cholangiopathy in liver transplantation using 
donors after cardiac death: the untold story. Surgery 2009; 146: 
543­552; discussion 552­553 [PMID: 19789011 DOI: 10.1016/
j.surg.2009.06.052]
13 Bickford RG, Winton FR. The influence of temperature on the 
isolated kidney of the dog. J Physiol 1937; 89: 198­219 [PMID: 
16994855 DOI: 10.1113/jphysiol.1937.sp003473]
14 Burg MB, Orloff J. Active cation transport by kidney tubules at O 
C. Am J Physiol 1964; 207: 983­988 [PMID: 14237472]
15 Suszynski TM, Rizzari MD, Scott WE, Eckman PM, Fonger JD, 
John R, Chronos N, Tempelman LA, Sutherland DE, Papas KK. 
Persufflation (gaseous oxygen perfusion) as a method of heart 
preservation. J Cardiothorac Surg 2013; 8: 105 [PMID: 23607734 
DOI: 10.1186/1749­8090­8­105]
16 Treckmann J, Minor T, Saad S, Ozcelik A, Malagó M, Broelsch 
CE, Paul A. Retrograde oxygen persufflation preservation of 
human livers: a pilot study. Liver Transpl 2008; 14: 358­364 
[PMID: 18306377 DOI: 10.1002/lt.21373]
17 Minor T, Isselhard W, Klauke H. Reduction in nonparenchymal cell 
injury and vascular endothelial dysfunction after cold preservation 
of the liver by gaseous oxygen. Transpl Int 1996; 9 Suppl 1: 
S425­S428 [PMID: 8959878 DOI: 10.1111/j.1432­2277.1996.
tb01667.x]
18 Minor T, Klauke H, Vollmar B, Menger MD, Isselhard W. Rat 
liver transplantation after long­term preservation by venous 
systemic oxygen persufflation. Transplant Proc 1997; 29: 410­411 
[PMID: 9123059 DOI: 10.1016/S0041­1345(96)00140­6]
19 Klauke H, Minor T, Vollmar B, Isselhard W, Menger MD. 
Microscopic analysis of NADH fluorescence during aerobic and 
anaerobic liver preservation conditions: A noninvasive technique 
for assessment of hepatic metabolism. Cryobiology 1998; 36: 
108­114 [PMID: 9527872 DOI: 10.1006/cryo.1997.2068]
20 Minor T, Klauke H, Isselhard W. Resuscitation of cadaveric livers 
from non­heart­beating donors after warm ischemic insult: a novel 
technique tested in the rat. Experientia 1996; 52: 661­664 [PMID: 
8698106 DOI: 10.1007/BF01925569]
21 Minor T, Isselhard W, Yamamoto Y, Obara M, Saad S. The 
effects of allopurinol and SOD on lipid peroxidation and energy 
metabolism in the liver after ischemia in an aerobic/anaerobic 
persufflation. Surg Today 1993; 23: 728­732 [PMID: 8400677 
DOI: 10.1007/BF00311713]
22 Lüer B, Fox M, Efferz P, Minor T. Adding pulsatile vascular 
stimulation to venous systemic oxygen persufflation of liver grafts. 
Artif Organs 2014; 38: 404­410 [PMID: 24117496 DOI: 10.1111/
aor.12184]
23 Saad S, Minor T, Kötting M, Fu ZX, Hagn U, Paul A, Nagels­
chmidt M. Extension of ischemic tolerance of porcine livers by 
cold preservation including postconditioning with gaseous oxygen. 
Transplantation 2001; 71: 498­502 [PMID: 11258427 DOI: 10.109
7/00007890­200102270­00003]
24 Dutkowski P, Furrer K, Tian Y, Graf R, Clavien PA. Novel short­
term hypothermic oxygenated perfusion (HOPE) system prevents 
injury in rat liver graft from non­heart beating donor. Ann Surg 
2006; 244: 968­976; discussion 976­977 [PMID: 17122622 DOI: 
10.1097/01.sla.0000247056.85590.6b]
25 Schlegel A, Graf R, Clavien PA, Dutkowski P. Hypothermic 
oxygenated perfusion (HOPE) protects from biliary injury in a 
rodent model of DCD liver transplantation. J Hepatol 2013; 59: 
984­991 [PMID: 23820408 DOI: 10.1016/j.jhep.2013.06.022]
26 ‘t Hart NA, der van Plaats A, Leuvenink HG, van Goor H, 
Wiersema­Buist J, Verkerke GJ, Rakhorst G, Ploeg RJ. Determ­
ination of an adequate perfusion pressure for continuous dual 
vessel hypothermic machine perfusion of the rat liver. Transpl Int 
2007; 20: 343­352 [PMID: 17326775 DOI: 10.1111/j.1432­2277.2
006.00433.x]
27 Schlegel A, Kron P, Graf R, Clavien PA, Dutkowski P. Hypo­
thermic Oxygenated Perfusion (HOPE) downregulates the immune 
response in a rat model of liver transplantation. Ann Surg 2014; 
260: 931­937; discussion 937­938 [PMID: 25243553 DOI: 
10.1097/SLA.0000000000000941]
28 Op den Dries S , Sutton ME, Karimian N, de Boer MT, 
Wiersema­Buist J, Gouw AS, Leuvenink HG, Lisman T, Porte 
RJ. Hypothermic oxygenated machine perfusion prevents arterio­
lonecrosis of the peribiliary plexus in pig livers donated after 
circulatory death. PLoS One 2014; 9: e88521 [PMID: 24551114 
DOI: 10.1371/journal.pone.0088521]
29 Guarrera JV, Estevez J, Boykin J, Boyce R, Rashid J, Sun S, 
Arrington B. Hypothermic machine perfusion of liver grafts for 
transplantation: technical development in human discard and 
miniature swine models. Transplant Proc 2005; 37: 323­325 
[PMID: 15808631 DOI: 10.1016/j.transproceed.2004.12.094]
30 Dutkowski P, Schlegel A, de Oliveira M, Müllhaupt B, Neff F, 
Clavien PA. HOPE for human liver grafts obtained from donors 
after cardiac death. J Hepatol 2014; 60: 765­772 [PMID: 24295869 
DOI: 10.1016/j.jhep.2013.11.023]
31 Olschewski P, Gass P, Ariyakhagorn V, Jasse K, Hunold G, Menzel 
M, Schöning W, Schmitz V, Neuhaus P, Puhl G. The influence of 
storage temperature during machine perfusion on preservation 
quality of marginal donor livers. Cryobiology 2010; 60: 337­343 
[PMID: 20233587 DOI: 10.1016/j.cryobiol.2010.03.005]
32 Berendsen TA, Bruinsma BG, Lee J, D’Andrea V, Liu Q, Izamis 
ML, Uygun K, Yarmush ML. A simplified subnormothermic 
machine perfusion system restores ischemically damaged liver 
grafts in a rat model of orthotopic liver transplantation. Transplant 
Res 2012; 1: 6 [PMID: 23369351]
33 Bruinsma BG, Yeh H, Ozer S, Martins PN, Farmer A, Wu W, 
Saeidi N, Op den Dries S, Berendsen TA, Smith RN, Markmann JF, 
Porte RJ, Yarmush ML, Uygun K, Izamis ML. Subnormothermic 
machine perfusion for ex vivo preservation and recovery of 
the human liver for transplantation. Am J Transplant 2014; 14: 
1400­1409 [PMID: 24758155 DOI: 10.1111/ajt.12727]
34 Friend PJ, Imber C, St Peter S, Lopez I, Butler AJ, Rees MA. 
Normothermic perfusion of the isolated liver. Transplant Proc 
2001; 33: 3436­3438 [PMID: 11750471 DOI: 10.1016/S0041­134
5(01)02481­2]
35 op den Dries S, Karimian N, Sutton ME, Westerkamp AC, Nijsten 
MW, Gouw AS, Wiersema­Buist J, Lisman T, Leuvenink HG, 
Porte RJ. Ex vivo normothermic machine perfusion and viability 
testing of discarded human donor livers. Am J Transplant 2013; 
Mahboub P et al . Approaches to improve DCD liver grafts
320 June 24, 2016|Volume 6|Issue 2|WJT|www.wjgnet.com
13: 1327­1335 [PMID: 23463950 DOI: 10.1111/ajt.12187]
36 Sutton ME, op den Dries S, Karimian N, Weeder PD, de Boer 
MT, Wiersema­Buist J, Gouw AS, Leuvenink HG, Lisman T, Porte 
RJ. Criteria for viability assessment of discarded human donor 
livers during ex vivo normothermic machine perfusion. PLoS 
One 2014; 9: e110642 [PMID: 25369327 DOI: 10.1371/journal.
pone.0110642]
37 Watson CJ, Kosmoliaptsis V, Randle LV, Russell NK, Griffiths 
WJ, Davies S, Mergental H, Butler AJ. Preimplant Normothermic 
Liver Perfusion of a Suboptimal Liver Donated After Circulatory 
Death. Am J Transplant 2016; 16: 353­357 [PMID: 26393945 
DOI: 10.1111/ajt.13448]
38 Minor T, Efferz P, Fox M, Wohlschlaeger J, Lüer B. Controlled 
oxygenated rewarming of cold stored liver grafts by thermally 
graduated machine perfusion prior to reperfusion. Am J Transplant 
2013; 13: 1450­1460 [PMID: 23617781 DOI: 10.1111/ajt.12235]
39 Minor T, Stegemann J, Hirner A, Koetting M. Impaired autophagic 
clearance after cold preservation of fatty livers correlates with 
tissue necrosis upon reperfusion and is reversed by hypothermic 
reconditioning. Liver Transpl 2009; 15: 798­805 [PMID: 19562717 
DOI: 10.1002/lt.21751]
40 Dutkowski P, Graf R, Clavien PA. Rescue of the cold preserved 
rat liver by hypothermic oxygenated machine perfusion. Am J 
Transplant 2006; 6: 903­912 [PMID: 16611326 DOI: 10.1111/j.16
00­6143.2006.01264.x]
41 Westerkamp AC, Mahboub P, Meyer SL, Hottenrott M, Ottens 
PJ, Wiersema­Buist J, Gouw AS, Lisman T, Leuvenink HG, Porte 
RJ. End­ischemic machine perfusion reduces bile duct injury in 
donation after circulatory death rat donor livers independent of the 
machine perfusion temperature. Liver Transpl 2015; 21: 1300­1311 
[PMID: 26097213 DOI: 10.1002/lt.24200]
42 Shapey IM, Muiesan P. Regional perfusion by extracorporeal 
membrane oxygenation of abdominal organs from donors after 
circulatory death: a systematic review. Liver Transpl 2013; 19: 
1292­1303 [PMID: 24136827 DOI: 10.1002/lt.23771]
43 Hessheimer AJ, Billault C, Barrou B, Fondevila C. Hypothermic 
or normothermic abdominal regional perfusion in high­risk donors 
with extended warm ischemia times: impact on outcomes? Transpl 
Int 2015; 28: 700­707 [PMID: 24797796 DOI: 10.1111/tri.12344]
44 Farney AC, Singh RP, Hines MH, Rogers J, Hartmann EL, 
Reeves­Daniel A, Gautreaux MD, Iskandar SS, Adams PL, 
Stratta RJ. Experience in renal and extrarenal transplantation with 
donation after cardiac death donors with selective use of extracor­
poreal support. J Am Coll Surg 2008; 206: 1028­1037; discussion 
1037 [PMID: 18471749 DOI: 10.1016/j.jamcollsurg.2007.12.029]
45 Suárez F, Otero A, Solla M, Arnal F, Lorenzo MJ, Marini M, 
Vázquez­Iglesias JL, Gómez M. Biliary complications after liver 
transplantation from maastricht category­2 non­heart­beating 
donors. Transplantation 2008; 85: 9­14 [PMID: 18192905 DOI: 
10.1097/01.tp.0000297945.83430.ce]
46 Hashimoto K, Eghtesad B, Gunasekaran G, Fujiki M, Uso TD, 
Quintini C, Aucejo FN, Kelly DM, Winans CG, Vogt DP, Parker 
BM, Irefin SA, Miller CM, Fung JJ. Use of tissue plasminogen 
activator in liver transplantation from donation after cardiac death 
donors. Am J Transplant 2010; 10: 2665­2672 [PMID: 21114643 
DOI: 10.1111/j.1600­6143.2010.03337.x]
47 Seal JB, Bohorquez H, Reichman T, Kressel A, Ghanekar A, 
Cohen A, McGilvray ID, Cattral MS, Bruce D, Greig P, Carmody 
I, Grant D, Selzner M, Loss G. Thrombolytic protocol minimizes 
ischemic­type biliary complications in liver transplantation from 
donation after circulatory death donors. Liver Transpl 2015; 21: 
321­328 [PMID: 25545787 DOI: 10.1002/lt.24071]
P- Reviewer: Balaban YH, Kruel CRP, Kita K, Marino IR, Sugawara Y 
S- Editor: Gong XM    L- Editor: A    E- Editor: Liu SQ 
Mahboub P et al . Approaches to improve DCD liver grafts
© 2016 Baishideng Publishing Group Inc. All rights reserved.
Published by Baishideng Publishing Group Inc
8226 Regency Drive, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgoffice@wjgnet.com
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
http://www.wjgnet.com
